ARCHIVES

In Brief: Best Guess On NCI Director: Brown First Choice, Benacerraf Second; FDa On Saccharin

This article is from The Cancer Letter archive.

Vol. 03 No. 16 | April 22, 1977

Download PDF Visit The Full Archive

Related Articles

Breast Cancer A Heterogeneous Disease, Concepts Changing: Fisher

June 13, 1980

In Congress: Funds Unavailable To Give NIH Big Raise, Appropriators Say

June 5, 1998

In Brief: Administration Backs Down On a Attempt To Kill General Research Support, Will Try To Modify It

November 1, 1974

FDA Oncology Division To Develop Papers On Expectations for New Drugs

August 2, 1996

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

March 25, 2011

NCI To Fund 29% Of Grants In 1990, With Budget Cuts

February 17, 1989